Formula Growth’s Caesarstone CSTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-165,588
Closed -$2.27M 156
2021
Q1
$2.27M Sell
165,588
-35,146
-18% -$465K 0.33% 92
2020
Q4
$2.59M Buy
200,734
+16,585
+9% +$189K 0.43% 66
2020
Q3
$1.8M Buy
+184,149
New +$1.99M 0.34% 85
2018
Q4
Sell
-273,079
Closed -$5.07M 143
2018
Q3
$5.07M Sell
273,079
-371,520
-58% -$6.52M 0.58% 45
2018
Q2
$9.73M Buy
644,599
+87,025
+16% +$1.49M 1.07% 31
2018
Q1
$11M Buy
557,574
+70,000
+14% +$1.51M 1.3% 24
2017
Q4
$10.7M Buy
487,574
+244,176
+100% +$6.27M 1.41% 22
2017
Q3
$7.25M Buy
243,398
+140,000
+135% +$4.38M 1.14% 28
2017
Q2
$3.62M Sell
103,398
-67,000
-39% -$2.51M 0.62% 45
2017
Q1
$6.18M Buy
170,398
+20,000
+13% +$644K 1.29% 19
2016
Q4
$4.31M Buy
150,398
+20,000
+15% +$635K 1% 29
2016
Q3
$4.92M Buy
130,398
+20,000
+18% +$757K 1.11% 28
2016
Q2
$3.84M Sell
110,398
-36,000
-25% -$1.33M 0.93% 34
2016
Q1
$5.03M Buy
146,398
+5,000
+4% +$179K 1.2% 22
2015
Q4
$6.13M Buy
+141,398
New +$5.39M 1.43% 16

Other funds holding CSTE

Formula Growth's CSTE Position: Q2 2021 in Review

Formula Growth sold out of Caesarstone (CSTE) in Q2 2021, closing a stake of 165,588 shares — an estimated $2.27M sold.

Formula Growth first reported a position in CSTE in Q4 2015 and held it in 15 quarters. The position peaked at $11M in Q1 2018. 118 funds tracked by Wall St. Rank hold CSTE as of Q2 2021.

  • Formula Growth reported no remaining Caesarstone position as of Q2 2021 after selling out during the quarter.
  • Formula Growth sold 165,588 Caesarstone shares in Q2 2021, an estimated $2.27M.
  • Formula Growth first reported a position in Caesarstone in Q4 2015 and held it in 15 quarters.
  • Formula Growth's Caesarstone position peaked at $11M in Q1 2018.
  • 118 funds tracked by Wall St. Rank held Caesarstone as of Q2 2021.

Based on Formula Growth's 13F filing for Q2 2021, filed 13 Aug 2021.